Clinical Trial Update: A Study of Substitution of 5-FU (Fluorouracil) by Capecitabine in Scheme of Chemo-radiotherapy in Patients With Squamous Cell Carcinoma of the Anal Canal. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial completed in Brazil evaluated substituting capecitabine for 5-FU in chemoradiotherapy for squamous cell carcinoma of the anal canal.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Canal Cancer
• Anal Canal Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Capecitabine (capecitabine)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Anal Canal Cancer. | Phase 2 | Status: COMPLETED